Clinical trials

#AI / data analytics / healthtech / informatics #Analysis #Assay development optimisation & technology #Automation / robotics #Business #Cellular assays #Chemical engineering #Clinical trials #Drug development #Drug discovery #Drug targets #Genomics #Lead discovery #Molecular medicine #Nanomedicine / nanotechnology #Pharmacogenomics #Pharmokinetics #Preclinical #Protein chemistry / Proteomics #RNA #Screening #Toxicology

Harnessing the CRO Intellect

Harnessing the CRO Intellect By Ian Lennox and Dr Nigel Brown There is no question that pharmaceutical companies are qualified to perform their own discovery and preclinical research. However, to fully exploit the new technologies in the early research phases, to maximise drug leads, and to minimise costs, would the… Read More

#Archive

#Biochemistry #Cell / tissue culture #Cell culture #Cell therapy #Clinical specialities #Clinical trials #Drug development #Drug discovery #Drug targets #Gene therapy #Genetics / genomes #Immunology #Immunology / Virology & Vaccines #Molecular medicine #Oncology #Protein chemistry / Proteomics #RNA #Stem cells #System biology #Therapeutics

The Genie in the Test Tube – From Gene to Gene Therapy: Part 1

The Genie in the Test Tube - From Gene to Gene Therapy: Part 1 By Dr Jan Steiner For thousands of years, medicine was a descriptive art, with treatments for disease arising from astute observation and trial and error. The rise of modern forms of biological sciences, especially the developments… Read More

#Archive

Close up of vaccine syringe
#AI / data analytics / healthtech / informatics #Animal models #Cell / tissue culture #Cell culture #Cell therapy #Cellular & Molecular biology #Clinical trials #Gene therapy #Genetics / genomes #Immunology #Immunology / Virology & Vaccines #Oncology #Pharmacology #Preclinical #Protein chemistry / Proteomics #RNA #Stem cells

Emerging therapeutic vaccines

Emerging therapeutic vaccines By Marc Hertz, Soren Mouritsen and Anand Gautam The excitement over the past 30 years for immunotherapy of cancer and other diseases has not led to the expected clinical successes. Over-enthusiasts predicted a cure for cancer with the initial development of monoclonal antibody technology, and later the… Read More

#Archive

Plant-based medicine
#Academic #Antimicrobials #Assay development optimisation & technology #Automation / robotics #Business #Cell culture #Cell therapy #Cellular assays #Chemical engineering #Chemistry #Clinical trials #Combinatorial chemistry #Drug development #Drug discovery #Gene therapy #Genomics #High throughput screening #Lead discovery #Medicinal chemistry #Pharmacology #Plant-based #Preclinical #Protein chemistry / Proteomics #Regulatory #RNA #Screening #Toxicology

Plants as a source of new medicines

By Jennie Gwynn and Peter J Hylands Putting aside the excitement surrounding the human genome, in the near future we may well start to see the emergence of a new class of prescription medicine containing complex mixtures of plant extracts. This article discusses the important role that plants can play… Read More

#Archive

#Academic #AI / data analytics / healthtech / informatics #Analysis #Analytical chemistry #Business #Chemistry #Clinical specialities #Clinical trials #Computational chemistry #Drug development #Drug discovery #Drug targets #Gene therapy #Genomics #In Silico Biology #Lead discovery #Regulatory #RNA #Therapeutics

Target discovery and drug design: extracting the value from genomics

By Professor Ken Powell, Deputy Director, Wolfson Institute for Biomedical Research Pharmaceutical research and development is changing. The old model of drug discovery, based on a combination of imprecise candidate generation and broad physiological screens, has given way to more specific and intelligent approaches to target identification and drug design. Read More

#Archive

#AI / data analytics / healthtech / informatics #Automation / robotics #Business #Chemical engineering #Clinical specialities #Clinical trials #Drug development #Drug discovery #Enabling technologies #Genomics #High Content Screening #Lead discovery #Protein chemistry / Proteomics #RNA

The Future Role of CROs

The Future Role of CROs By John M Hall PhD and Ludo Reynders PhD The increasing reliance by big pharmaceutical companies on CROs presents a mixture of challenges and opportunities for the industry. Given that the majority of customers are global in their reach, the CRO industry must be prepared… Read More

#Archive

#Academic #AI / data analytics / healthtech / informatics #Analysis #Assay development optimisation & technology #Automation / robotics #Business #Cellular assays #Chemistry #Clinical trials #Drug development #Drug discovery #Drug targets #Enabling technologies #Genetics / genomes #Genetics / genomics #Genomics #High Content Screening #Lead discovery #PCR #RNA #Sequencing #Stem cells #Toxicology

Using Expression Databases for Drug Discovery

Using Expression Databases for Drug Discovery By Dr Greg Lennon Reference databases are being built cataloguing the amount of RNA each gene makes under different conditions and in different individuals. These databases can be mined easily and effectively to aid the drug discovery process. The success of the Human Genome… Read More

#Archive